The synthesis of a chitobiosylated peptide thioester by the t-butoxycarbonyl (Boc) strategy is demonstrated. Boc-Asn carrying benzyl-protected chitobiose was introduced during application of the Boc mode solidphase method. HF treatment of the resulting protected peptide resin gave the desired chitobiosylated peptide thioester. This thioester was used to prepare the peptide sequence derived from extracellular matrix metalloproteinase inducers (emmprin) (34-94), (34-118) and by the thioester segment condensation method. The conformation of these glycopeptides is characterized by circular dichroism (CD) spectral measurement.
Peptide thioesters have been widely used as key intermediates for the preparation of polypeptides by segment condensation strategies such as the thioester method 1, 2) and native chemical ligation method. 3, 4) The former method involves the thioester group of the Nterminal partially-protected peptide being activated by silver ions and the amide bond formed with the Cterminal peptide. The latter uses the thioesterification reaction between the thioester group of the N-terminal peptide and the thiol group of the terminal cysteine residue of the other peptide, this being followed by the intramolecular S to N acyl migration reaction to form a native peptide bond. The preparation of peptide thioesters has been mainly carried out by the Boc strategy, in which the peptide chain is elongated by repetitive acid treatment to remove the Boc group and then deprotected by a stronger acid treatment such as with HF. Increasing interest in such post-translational modification as glycosylation has resulted in the development of thioester preparation by the Fmoc strategy which does not use a harsh acid treatment for the deprotection step. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] These methods have been successfully used to prepare peptide thioesters carrying an O-linked single N-acetylgalactosamine, 7) seven N-acetylgalactosamines 17, 18) and N-linked core pentasaccharide. 14, 15) However, the Fmoc strategy does not always give satisfactory results. As an extreme case, Marcaurelle et al. have reported that they could not obtain a peptide thioester by the Fmoc strategy when using the safety catch linker because of failure of thiolysis at the final step, whereas the Boc strategy successfully gave the desired product. 19) Thus, depending on the peptide sequence, the Boc strategy is more reliable than Fmoc strategy. However, due to the sensitivity of glycosidic linkages to strong acids, the Boc strategy has seldom been applied to the preparation of glycosylated peptide thioesters. [20] [21] [22] [23] Its applicability and limitations still remain unclear. We have briefly reported the preparation of a chitobiosylated thioester by the Boc strategy and its application to the synthesis of the extracellular matrix metalloproteinase inducer, emmprin 24, 25) (34-94), by the thioester method. 23) We report here the full experimental details. In addition, the glycosylated peptide thioester was further applied to the synthesis of the larger glycopeptides, emmprin (34-118) 4 as well as (22-118) 5 by using repeated segment coupling by the thioester method (Fig. 1) . The effect of chain length on the conformation was analyzed by CD spectral measurement of these glycopeptides.
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Results and Discussion
Emmprin is a heavily glycosylated protein located on the surface of tumor cells. It stimulates nearby fibroblasts to produce MMPs, which are key enzymes for tumor metastasis. 24, 25) In this respect, emmprin is viewed as a clinical target for the suppression of tumor metastasis. The functional site is presumed to be the first Ig domain (34-94) which has an N-glycosylation site at Asn 44 . However, direct evidence that the first Ig domain itself possesses collagenase stimulation activity has not been presented so far. Moreover, the significance and the structure of the carbohydrate at Asn 44 has not been clearly elucidated. To clarify these points and the mechanism for tumor metastasis, we synthesized the extracellular domains of emmprin carrying carbohydrates at Asn 44 .
Synthesis of chitobiosylated Ig domain (34-94)-NH 2 by the thioester method
The first Ig domain (34-94) is composed of 61 amino acid residues, in which Asn 44 is an N-glycosylation site (Fig. 1) . To effectively obtain this long glycopeptide, the sequence was divided in two, and segment condensation by the thioester method was carried out.
Gly
58 -Gly 59 was selected as a ligation site, since no precaution is required to prevent epimerization during segment coupling. Based on the reported stability of the chitobiose moiety to an HF treatment, 26) the N-terminal chitobiosylated peptide thioester was prepared by the Boc strategy as shown in Fig. 2 . To introduce the chitobiose moiety, Boc-Asn(GlcNAc 2 Bn 5 ) 11 was prepared by coupling known protected chitobiose unit 9 27) to the anhydride of the Boc-Asp derivative as shown in Fig. 3 . Following the previous protocol for peptide thioester preparation, 23) the peptide chain was assembled on Boc-Gly-SCH 2 CH 2 CO-Leu-OCH 2 -Pam-resin by an ABI 433A peptide synthesizer with the Boc/HOBt/ DCC protocol. The protected peptide resin corresponding to the sequence of emmprin (45-58) was then reacted with the benzotriazolyl ester of Boc-Asn(GlcNAc 2 Bn 5 ) 11 (2 eq to the peptide on resin). The remaining sequence was again introduced by the synthesizer. After assembly of the sequence (34-58) had been completed, a part of the resin was stored for the synthesis of (22-58). The remaining resin was treated with HF at 0 C for 1.5 h. Analysis of the crude peptide by RPHPLC showed that the desired chitobiosylated peptide thioester had been obtained in a good yield. In addition to the desired product, however, a peptide thioester carrying GlcNAc The arrows indicate the site of segment coupling.
was also obtained in about a two-thirds ratio, which might have been derived from cleavage of the GlcNAcGlcNAc bond by the HF treatment. Thus, under the standard HF treatment conditions (the concentration of HF was more than 80%), the chitobiose did not retain complete stability. Treatment with a decreased concentration of an acid, such as a low-HF treatment, 28) might overcome this problem. However, it would be worth noting that the yield of the desired peptide was 6.7%, which is about 4 times higher than that of the same peptide thioester carrying an N-linked core pentasaccharide by the Fmoc strategy (1.8% yield). 14) This result demonstrates that, in the case of a peptide thioester carrying chitobiose, the Boc strategy would be the method of choice in respect of the yield of the product. The resin stored at (34-58) was used for further elongation by the Boc strategy to obtain the protected peptide resin of . HF treatent of this resin gave the desired peptide and the GlcNAc-truncated peptide in almost the same ratio as that of the (34-58) peptide thioester. This result indicates that the stability of chitobiose to HF seems to have been independent of its local environment within the peptide. The thioester method uses activation of the thioester group by silver ions to acylate the terminal amino group of the amino component. Thus, other amino and thiol groups were protected to suppress side reactions. Introduction of the Boc groups was easily achieved by Boc-OSu in the presence of DIEA. By following the same procedure, non-glycosylated peptide thioester 8 was obtained.
C-terminal peptide (59-94) 12 was prepared with the Fmoc strategy by the FastMoc protocol, which used HBTU as a coupling reagent, as shown in Fig. 4 . The protected peptide resin was treated with TFA (Reagent K 29) ), and the crude peptide was purified by RPHPLC. Synthesis of this peptide was accompanied by a significant amount of an aspartimide side product (about 30%) which could not be removed by RPHPLC. The peptide was further purified by anion-exchange to remove the by-product and was again desalted by RPHPLC. This two-step purification enabled a highly pure product to be obtained in a comparable yield to that of the N-terminal peptide thioester. Protection of the side-chain amino groups and subsequent removal of the terminal Fmoc group were then carried out for segment coupling with the N-terminal peptide thioester.
The segment coupling reaction by the thioester method was carried out as shown in Fmoc-Rink amide MBHA-resin (Fmoc-NH-resin) and 12 were dissolved in DMSO containing HOOBt and DIEA. The thioester group was then activated by silver ions. The coupling reaction was almost completed within 6 h without significant side reactions. The Boc and Acm groups of the peptide were respectively removed by TFA and AgNO 3 . The peptide was purified by RPHPLC, and the disulfide bond was formed by airoxidation in 1% AcONH 4 (pH 7.8) overnight. Final product 1 was successfully obtained after RPHPLC purification. The chitobiose unit was stable throughout the segment coupling reaction. The glucosaminylated and non-glycosylated Ig domains (34-94)-NH 2 2, 3 were prepared by following the same procedure (Fig. 6 ).
Synthesis of chitobiosylated emmprin (34-118)-NH 2 4 and (22-118)-NH 2 5 by the thioester method
The thioester method was further applied to the larger glycopeptides, emmprin (34-118) 4 and (22-118) 5, by repetition of the segment coupling as shown in Fig. 7 . To achieve repetition of the coupling, the terminal amino group of middle segment 14 was orthogonally protected by the Fmoc group to the side chain amino group. This peptide thioester was prepared by the Boc strategy. The N-terminal glycine was introduced by using Fmoc-Gly. C-terminal peptide 15 was synthesized by the Fmoc strategy according to the same procedure as that used for peptide 12.
To synthesize of glycopeptide 4, peptides 14 and 15 were condensed by the same procedure as that used for (34-94)-NH 2 , using activation of the thioester group by silver ions. The reaction was completed without significant side reactions within 12 h. The terminal Fmoc group was then removed by piperidine. The crude peptide obtained was used for the second coupling reaction with glycopeptide thioester 6 without further purification. This reaction also proceeded smoothly (Fig. 8a) . After the Boc and Acm groups had been removed (Fig. 8b) , the crude peptide was purified by RPHPLC to obtain glycopeptide 17. This reduced form of the product was air-oxidized to form a disulfide bond (Fig. 8c) . After HPLC purification, final product 4 was successfully obtained with high purity as shown in Fig. 8d .
The thioester method was further applied to the synthesis of (22-118) which was composed of 97 amino acid residues. Ala 22 of this peptide is presumed to be the N-terminal of the native emmprin. Peptides 14 and 15 were condensed as already described. Obtained crude peptide 16 was further coupled with glycopeptide thioester 13 by the thioester method. completed within 12 h without serious side reactions as shown in Fig. 9a . Removal of the Boc and Acm groups was then carried out as described for glycopeptide 4. This reaction proceeded smoothly (Fig. 9b) . In contrast to glycopeptide 17, the isolation of 18 was difficult, as it was highly adsorbed to the HPLC column. The reason for this low recovery might be attributable to the Nterminal sequence being abundant in hydrophobic amino acids. The purification was therefore carried out by gel filtration chromatography using 50% aqueous acetonitrile containing 0.1% TFA. The disulfide bond formation was first attempted in an ammonium acetate buffer (pH 8.0). However, most of the peptide was precipitated. This precipitate was dissolved in 6 M guanidine hydrochloride containing DTT. Glycopeptide 18 was recovered by gel filtration chromatography and oxidized for 2 days in ammonium acetate (pH 8.0) containing 6 M guanidine hydrochloride (Fig. 9c) . The solution was loaded into a gel chromatography column and the desired product 5 was obtained (Fig. 9d) . The MALDI-TOF mass analysis, and an amino acid composition analysis confirmed that the desired product had been successfully synthesized.
CD spectrum of the synthetic emmprin glycopeptides
The synthetic glycopeptides were dissolved in a sodium phosphate buffer (pH 7.0), and the secondary structure was characterized by CD spectral measurement. As shown in Fig. 10 , there was a distinct difference between non-glycosylated peptide 3 and glycosylated peptides 1, 2, 4 and 5. The biological activity of peptides 1, 2 and 3 was preliminarily measured by Nabeshima et al. (unpublished data). The results show that the MMP stimulation activity increased as the sugar chain became longer from GlcNAc 2 to chitobiose 1, whereas the Ig domain itself, 3, had no activity. This result corresponds well with the CD spectrum. The [] values for peptide 4 and 5 were considerably larger in the negative direction than those of glycopeptides 1 and 2, indicating that a more stable conformation was formed by elongation of the peptide chain. However, the spectra of these glycopeptides indicate that the peptide did not assume a structure rich in -strand, which has been observed for immunoglobulins and Ig-like domains.
30) The reason for this result
is not yet known. However, the result might indicate that other factors beside the peptide chain length also contributed to the folding of this peptide. Emmprin retains large carbohydrates with a molecular weight of about 30 kDa, which is comparable to the molecular weight of its polypeptide chain, 27 kDa. This fact might show that, at the small chitobiose level, glycosylation at Asn 44 only altered the conformation around Asn 44 to exert emmprin activity, but did not stabilize the entire Ig domains to take a particular conformation. It is therefore possible that a larger oligosaccharide chain would be required to assume the correct three-dimensional structure of emmprin. It might also be possible that further elongation of the peptide chain could induce a more stable comformation. Synthesis of the Ig domain carrying a more complex carbohydrate as well as synthesis of a longer extracellular chain are required to clarify this point.
In conclusion, a chitobiosylated peptide thioester was prepared by the Boc strategy and used for the preparation of chitobiosylated emmprin (34-94)-NH 2 . The larger glycopeptides, (34-118)-NH 2 and (22-118)-NH 2 , were successfully prepared by repetitive segment coupling, which demonstrates the usefulness of the thioester method for the synthesis of glycoproteins. Elongation of peptide chain contributed to a stabilized conformation. The biological activity of these glycosylated peptides is under study.
Experimental
Optical rotation values were determined with a DIP- 370 polarimeter (Jasco, Tokyo, Japan) for solutions in CHCl 3 .
1 H-NMR spectra were recorded with an AL400 spectrometer (Jeol, Tokyo, Japan). Chemical shifts are expressed in ppm downfield from the signal for the internal Me 4 Si standard in pyridine-d 5 . TLC was performed on 60 F 254 silica gel (Merck). MALDI-TOF mass spectra were recorded with a Voyager-DE PRO spectrometer (Applied Biosystems, CA, USA). The amino acid composition was determined with a LaChrom amino acid analyzer (Hitachi, Tokyo, Japan) after hydrolysis with 6 M HCl at 150 C for 2 h in an evacuated sealed tube. Calculation of the peptide content was based on the amino acid analysis data. Compound 9 was prepared as reported previously. 27 ) (10) . A mixture of Boc-Asp-OFm (180 mg, 0.44 mmol) and DCC (50 mg, 0.24 mmol) was dissolved in CH 2 Cl 2 (0.44 ml) at 0 C, and the solution was stirred for 30 min. The precipitate was filtered, and the filtrate was concentrated in vacuo. The residue was dissolved in THF (5.2 ml) and added to a mixture of compound 9 (100 mg, 0.11 mmol) and a Lindlar catalyst (50 mg) under Ar. After the mixture had been stirred for 43 h under an H 2 atmosphere, the catalyst was filtered through Celite. The filtrate was purified on silica gel with (11) . To a solution of compound 10 (50 mg, 39 mmol) in DMF (1.6 ml) was added piperidine (0.4 ml), and the solution was stirred for 30 min. The solvent was removed in vacuo, and the residue was dissolved in CHCl 3 -methanol containing acetic acid (1:1:0.01). The solution was loaded onto LH-60 with CHCl 3 -methanol (1:1). The major fraction was collected to give compound 11 (49 mg, quantitative). R f 0.38 (9:1:0.1 CHCl 3 -methanol-AcOH). ½ D þ11:0 (c 0.5, CHCl 3 ). 1H, H-2a CO-Leu (6, n ¼ 2; 7, n ¼ 1). Starting from Boc-Gly-SCH 2 CH 2 CO-Leu-OCH 2 -Pam-resin (0.74 mmol/g, 0.14 g), the peptide chain was elongated by a 433A peptide synthesizer (Applied Biosystems, CA, USA), using 0.1 mmol Boc/HOBt/ DCC. The brief procedure for this protocol is as follows: 1) TFA deprotection (25% TFA/CH 2 Cl 2 for 3 min, 50% TFA/CH 2 Cl 2 for 11 min), 2) CH 2 Cl 2 wash (Â4), 3) DIEA neutralization (5% DIEA/NMP for 0.5 min Â2), 44 , Cys(Acm) 41 ]-emmprin (34-58)-SCH 2 CH 2 CO-Leu (6.5 mmol) was dissolved in DMSO (0.2 ml), and Boc-OSu (7.6 mg, 35 mmol) and DIEA (6.2 ml, 36 mmol) were added. After the reaction mixture had stood for 2 h at room temperature, the product was precipitated by ether, washed twice with ethyl acetate and lyophilized from the dioxane suspension to give peptide 6 (4.8 mmol, 74% (13) . Using the resin stored at Gly 34 during the synthesis of 6 and 7 (13 mmol), the peptide chain was further elongated by the 0.1 mmol Boc/HOBt/DCC protocol to obtain Boc-Ala-Ala-Gly-Thr ( . This resin (86 mg) was treated with HF (2.5 ml) containing anisole (0.1 ml) and 1,4-butanedithiol (0.4 ml) at 0 C for 1.5 h. After HF had been evaporated in vacuo, the crude peptide was washed with ether (Â3), extracted with 50% aqueous acetonitrile containing 0.1% TFA and lyophilized. The analysis of the crude peptide showed that the desired product and GlcNActruncated peptide thioester had been obtained in 3:2 ratio. (8) . Starting from Boc-Gly-SCH 2 CH 2 CO-Nle-NH-resin (0.42 mmol/g, 1.2 g), the peptide chain was elongated by an ABI 433A peptide synthesizer, using 0. 4 g ) was obtained. A part of this resin (600 mg) was treated with HF (10 ml) containing anisole (0.5 ml) and 1,4-butanedithiol (1.5 ml) at 0 C for 1.5 h. After HF had been evaporated in vacuo, the crude peptide was washed with ether (Â3), extracted with 50% aqueous acetonitrile containing 0.1% TFA and lyophilized. (12) . Starting from Fmoc-Rink amide-MBHA-resin (0.54 mmol/g, 0.46 g), the peptide chain was elongated by an ABI 433A peptide synthesizer, using the 9 g ), was obtained by this protocol. A part of the resin (400 mg) was treated with Reagent K 29) (5.0 ml) for 2 h at room temperature. TFA was removed in a nitrogen stream, and the peptide was precipitated by ether. The peptide was dissolved in a 0.1 M sodium phosphate buffer (pH 6.0) and loaded into an anion-exchange column (ICE DEAE-825, 8 mm Â 75 mm; Showa Denko, Tokyo, Japan) which had been equilibrated with 0.1 M sodium phosphate (pH 6.0), before eluting with an increasing NaCl concentration in the buffer. The peptide was desalted by RPHPLC to give Fmoc-[Cys (Acm) 87 ]-emmprin (59-94)-NH 2 (5.6 mmol, 10% based on the amino groups in the initial resin). This peptide (5.6 mmol) was dissolved in DMSO (0.2 ml), and Boc-OSu (12 mg, 56 mmol) and DIEA (9.4 ml, 54 mmol) were added. After the solution had been kept at room temperature for 5 h, the product was precipitated by ether and washed with ethyl acetate. The obtained peptide was dissolved in DMSO (0.2 ml) containing 5% piperidine. The solution was kept at room temperature for 1 h, and the product was precipitated by ether and dried. The peptide was washed with 0.1% TFA and lyophilized to give peptide 12 (4.8 mmol, 8.9% based on the amino groups in the initial resin 
